Antidepressant drug pipeline: What to know

There are promising developments in the pipeline for patients with treatment-resistant depression. Read more.

Four things to know to combat rising drug spend

Executives need to ask themselves four key questions to mitigate the negative impact of rising drug costs. Read more.

Remicade will now have a biosimilar

Expectations are high that biosimilars can control overall biologic cost growth. Read the latest developments.

MOST POPULAR IN PHARMACY

Asthma drug pipeline: Prevalence, costs to increase

September 02, 2016

Get the free app!

Part of the

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us